Introduction
Prostate cancer (PC) is a malignant tumor in genitourinary system, which is a serious threat to the male population [
1]. Most patients undergo surgery, radiation, chemotherapy or hormone therapy. Despite improvements in these treatments, the 5-year recurrence rate for men with PC is still about 25 percent, and the overall mortality remains high [
2]. It is well-known that the development and maintenance of the prostate depends on the action of androgen through the androgen receptor (AR) [
3]. AR plays pivotal roles in PC progression [
4]. About 80–90% of prostate cancers depend on androgens at the time of initial diagnosis [
5]. Androgen deprivation therapy that targets AR is the primary treatment for metastatic PC and has shown therapeutic benefits for numerous patients, but patients inevitably develop into castration-resistant PC after androgen deprivation therapy [
6,
7]. Exploring the molecular mechanisms associated with the role of AR in PC will accelerate the development of treatment target.
Among eukaryotes, except for the established epigenetic DNA modifications, RNA modifications are also prevalent. N6-methylladenosine (m6A) is one of the most common and reversible modifications on mRNA [
8]. Now, it is well-known that m6A is regulated by the methyltransferases (writers, such as METTL14, METTL3 and WTAP), demethylases (erasers, including ALKBH5 and FTO) and RNA-binding proteins (readers, such as YTHDC1/2, YTHDF1/2/3, and IGF2BP1/2/3) [
9,
10]. Dysregulation of m6A modification participates in various pathological processes, particularly in tumorigenesis, including the progression of PC. It has been reported that m6A methyltransferase METTL3 can promote the progression of PC via m6A-modified LEF1 [
11]. In addition, Cai et al. [
12] reported that METTL3 promoted the growth of PC. More recently, Zhu et al. [
13] suggested that m6A demethylase FTO inhibited the migration and invasion of PC cells by regulating the total m6A levels. Xia et al. [
14] demonstrated that m6A-induced suppression of SIAH1 facilitated alternative splicing of androgen receptor variant 7 by regulating CPSF1 in PC. To our best knowledge, there is no report about the direct relationship between m6A modification-associated genes and AR-related genes in PC. Given the important roles of AR in PC and m6A modification in PC, we speculated that m6A methylation may be associated with the pathogenesis of PC by regulating androgen function-related genes.
Thus, in this study, we first screened m6A genes that were associated with androgen function in PC cells by treating cells with AR inhibitor. Then we clarified the regulatory mechanisms of this m6A gene on the progression of PC through in vitro and in vitro experiments. Our study may provide novel directions in clinical treatment of PC.
Discussion
As the most common chemical methylation on mRNAs in human, m6A regulators, including writers, easers and readers, have recently been considered essential for biological regulation of human cancers [
9,
15]. PC is one of the leading malignant tumors among male population [
16,
17]. Our study for the first time uncovered a direct role of m6A-modified-binding protein YTHDF1 in regulating androgen function-related genes by regulating TRIM68 in PC.
As we known, PC is a hormonally regulated malignancy, and AR plays a key role in the progression of PC [
18]. AR is a transcription factor and can collaboratively regulate the effects of androgens with some co-regulatory factors. AR up-regulates or down-regulates the expression of target genes through coactivators or co-repressors [
19,
20]. The activity of AR and coregulatory factors is regulated by post-translational modifications such as methylation, and ubiquitination [
21,
22]. Interestingly, the methylation modification has been proved in our study. Previous studies have found that expression of METTL3 and WTAP are regulated by androgen in PC cell lines, as well as increased expression of METTL3 plays a pro-tumor role in PC, while METTL3 silencing resulted in upregulation of AR, together with 134 AR-regulated genes [
23,
24]. Another study showed that the overall level of m6A in castration resistance PC was increased compared to the castration sensitive PC, and METTL3 could activate ERK pathway, and induce the resistance to AR inhibitor (Enzalutamide) in PC. Taken together, it can be inferred that alteration of m6A levels is closely connected with the occurrence and development of PC.
It has been reported that the translation of AR mRNA is coordinated and regulated by RNA-binding proteins YTHDF3 and G3BP1; as well as m6A-modified AR mRNA is bound to YTHDF3 and translationally stimulated, whereas m6A-unmodified AR mRNA is bound with G3BP1 and translationally inhibited [
25]. Another study manifested that YTHDF1, YTHDC2, and YTHDF2 were up-regulated in PC, and had positive correlation with the Gleason grades of PC, as well as the m6A levels were higher in the LNCAP cells [
26] Furthermore, m6A regulators are reported to have positive correlation with AR, and play important roles in PC progression [
26]. YTHDF1, similar with YTHDF3, is also the most abundant reader of m6A-modified mRNA, which functionally connects m6A-modified mRNA to its fate [
27]. YTHDF1 is necessary for protein translation [
28‐
30]. Many studies have reported that YTHDF1 plays a critical role in tumor biology by influencing the expression of some key factors or by regulating the protein translation of key genes associated with the important signaling pathways[
31‐
33]. YTHDF1 has been demonstrated to promote the metastasis of gastric cancer in an m6A-dependent way by promoting USP14 translation [
34]. Wang et al. [
35] have revealed that YTHDF1 can aggravate the progression of cervical cancer by m6A-mediated up-regulation of RANBP2. Liu et al. [
36] reported that YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Recently, Li et al. [
37] demonstrated that YTHDF1 was overexpressed in PC cells, knockdown of which suppressed the proliferation, and invasion of PC cells by regulating TRIM44. Another study also reported that YTHDF1 was up-regulated in PC tissue and was related to an adverse prognosis in patients with PC [
38]. However, these studies focused on the function of YTHDF1 in cancer progression, its role in androgen function has not been reported to our knowledge. Our results revealed that YTHDF1 was down-regulated in AR inhibitor groups. Knockdown of YTHDF1 suppressed the AR level, cell viability, migration, and invasion, and increased the apoptosis of PC cells. In vivo experiments obtained similar results. These results, together with the reports, we speculate that YTHDF1 may function as a carcinogenic factor by increased the AR level in PC, and co-action of AR signaling system and m6A modification may play essential roles in the development and progression of PC.
To further reveal the possible molecular mechanisms of YTHDF1 affecting AR in PC, we conducted MeRIP sequencing and bioinformatics analysis. Based on our results, TRIM68 was selected as a candidate target of YTHDF1. TRIM68 belongs to the tripartite motif-containing protein family that is defined by the common domain structure of a B-box, a Ring finger, and a coiled-coil motif [
39]. A previous study has demonstrated that TRIM68 is preferentially expressed in PC cells. It acts as a coactivator of AR through its ubiquitin ligase activity. Overexpression of TRIM68 could enhance AR-mediated transcriptional activation, while knockdown of TRIM68 could inhibit AR-mediated transcriptional activation in PC cells [
40]. In this study, we revealed that knockdown of TRIM68 alone had similar role with YTHDF1 knockdown in PC cells. Importantly, TRIM68 overexpression could reverse the effects of YTHDF1 knockdown in PC both in vitro and in vivo. To our best knowledge, our study for the first time demonstrated that relationship between TRIM68 and m6A methylation (YTHDF1) in PC.
However, there are some limitations in our study. First, the roles of YTHDF1 or TRIM68 in PC should be further investigated in the androgen adding system. Second, the reasons for the decreased m6A modification after YTHDF1 knockdown (whether modify the expression of m6A writers or erasers) remain unclear, and need to be explored in the future. In addition, the further in-depth mechanism research of YTHDF1 and TRIM68 (including mRNA transcription, translation, stability, and their upstream and downstream relationships) is also necessary to be unearthed in the future through various techniques, such as immunofluorescence staining localization, RIP-qPCR, and rescue assays.
In conclusion, our study demonstrated the key role of YTHDF1-mediated m6A modification in PC progression by regulating androgen function-related gene TRIM68 in PC. The findings will aid in the development of therapeutic strategies against PC.
Materials and methods
Cell culture
Human prostate normal cells (RWPE2), and PC cell lines LNCAP, DU145 and PC-3 cells were purchased from Cell Bank of the Chinese Academy of Sciences (Shanghai, China). The RWPE2 cells were maintained in the defined keratinocyte–SFM (Thermo Fisher Scientific, USA) containing with 10% fetal bovine serum (FBS, Thermo Fisher Scientific) and 1% penicillin/streptomycin (Thermo Fisher Scientific); as well as the LNCAP, DU145 and PC-3 cells were maintained in RPMI-1640 medium (Thermo Fisher Scientific) supplemented with 10% FBS and 1% penicillin/streptomycin. All the cells were cultured in an incubator with 5% CO2 at 37 °C.
Cell counting kit-8 (CCK-8) assay
Cells were seeded in a 96-well plate (1 × 104 cells/well) overnight. The cells were then treated with different concentrations of AR inhibitor (ARN-509; SD0033-10 mM, Beyotime, China) (0, 1, 5, 10, 50, 100 μM) for 48 h. After that cells were treated with 10 µl of CCK-8 reagent (C0038; Beyotime, China) for 2 h. The absorption values were measured at 450 nm. The cell viability curve was plotted.
Quantitative real-time PCR (qRT-PCR)
For cells, total RNA was isolated from the cells with different treatments (n = 3 for each group) using RNAiso Plus (Takara, Japan) following the manufacturer’s instructions. Then, the isolated total RNA was reverse transcribed into cDNA with PrimeScript RT Master Mix (Takara). The temperature protocol of reserve transcription was 37 °C for 60 min and 85 °C for 5 s. After that, Power SYBR Green PCR Master Mix (Thermo, Waltham, MA, USA) was used to perform a real-time PCR according to the manufacturer’s protocols. The reaction was initiated at 50 °C for 2 min, a total of 40 cycles at 95 °C for 2 min, 95 °C for 15 s, and at 60 °C for 60 s, and then melted at 95 °C for 15 s, 60 °C for 60 s, and 95 °C for 15 s. The primers used in this experiment are shown in Table
1, and GAPDH was used as the reference gene. The relative changes in the transcriptional levels of all genes were calculated using 2
−∆∆Ct method.
Table 1
Primers used in this study
AR | Forward | CCAGGGACCATGTTTTGCC |
AR | Reverse | CGAAGACGACAAGATGGACAA |
METTL3 | Forward | TTGTCTCCAACCTTCCGTAGT |
METTL3 | Reverse | CCAGATCAGAGAGGTGGTGTAG |
METTL14 | Forward | AGTGCCGACAGCATTGGTG |
METTL14 | Reverse | GGAGCAGAGGTATCATAGGAAGC |
WTAP | Forward | CTTCCCAAGAAGGTTCGATTGA |
WTAP | Reverse | TCAGACTCTCTTAGGCCAGTTAC |
FTO | Forward | ACTTGGCTCCCTTATCTGACC |
FTO | Reverse | TGTGCAGTGTGAGAAAGGCTT |
ALKBH5 | Forward | CGGCGAAGGCTACACTTACG |
ALKBH5 | Reverse | CCACCAGCTTTTGGATCACCA |
YTHDF1 | Forward | ACCTGTCCAGCTATTACCCG |
YTHDF1 | Reverse | TGGTGAGGTATGGAATCGGAG |
YTHDC1 | Forward | AACTGGTTTCTAAGCCACTGAGC |
YTHDC1 | Reverse | TGTGCAGTGTGAGAAAGGCTT |
SMARCA4 | Forward | GACCAGCACTCCCAAGGTTAC |
SMARCA4 | Reverse | CTGGCCCGGAAGACATCTG |
TIPARP | Forward | AGAACGAGTGGTTCCAATCCA |
TIPARP | Reverse | TGGGTGCAAAAGATCAGTCTG |
TRIM68 | Forward | GGAGCCCATGAGCATTGACT |
TRIM68 | Reverse | GACAGGTGTAACCCCAGTTCT |
GAPDH | Forward | TGACAACTTTGGTATCGTGGAAGG |
GAPDH | Reverse | AGGCAGGGATGATGTTCTGGAGAG |
Western blot
Cells with different treatments (n = 3 for each group) were homogenized with RIPA solution (Beyotime) on the ice for 30 min. After centrifugation at 12,000 g for 10 min, the total protein concentrations were measured by a BCA Protein assay kit (Beyotime). Then, the protein samples (20 μg) were separated by 10% SDS–PAGE, and transferred to the PVDF membranes (IPVH00010; Millipore, USA). After being blocked in 5% skim milk at 37 °C for 1 h, the membranes were incubated with the primary antibodies (anti-AR (1:5000; 22,089-1-AP; Proteintech, China), anti-YTHDF1 (1:1000; 17,479–1-AP; Proteintech), and TRIM68 (1:1000; bs-17123R; Bioss, Warsaw, Poland)) at 4 ℃ overnight, and then incubated with the secondary antibody (1:5000; 111–035-003; Jackson immune research, USA) at 37 °C for 2 h. Finally, the expression levels of the related proteins were detected by an ECL kit, and visualized by Image Quant LAS 4000mini (GE Healthcare, USA).
Plasmid preparation
LB agar plates were prepared using 3.2 g LB Broth Agar and 80 mL ddH2O, followed by autoclave-based sterilization. Then, the media were cooled to below 60 °C, and ampicillin was added to a final concentration of 100 μg/mL. The LB agar media was prepared using 7.5 g LB Broth Medium and 300 mL ddH2O, followed by autoclave-based sterilization.
Under sterile conditions, 1 μL of plasmids (50–100 ng) were added into DH5α competent cells and placed on ice for 30 min. After standing at 42 °C for 90 s, cells were quickly transferred to the ice for 3–5 min. Then, 800 μL LB agar media (without ampicillin) was added and shaken at 100–150 rpm for 50 min. After that, 200 μL liquid was sucked out and added into solid LB agar plate (containing ampicillin), and cultured in 37 °C incubator overnight for 14–18 h. After transformation, monoclonal colonies were selected with sterile toothpick into liquid LB medium containing ampicillin and shaken gently for 8 h (220 rpm) at 37 °C. Plasmid DNA was extracted using the Endo-Free Plasmid Midi kit (Omega Bio-Tek, Norcross, GA, USA).
Cell transfection
The cells were re-suspended with complete culture medium, and then seeded into 24-well plates at 4 × 104 cells/well. The plasmids above were co-transfected using the Lipofectamine 2000 reagent (11,668–027; Thermo) in accordance with the instruction of the manufacturer.
Flow cytometry
The cells of each group were digested with trypsin. After centrifugation, cells were collected and apoptosis rates were detected by flow cytometry using an Annexin V-FITC/PI detection kit (556,420; BD Biosciences, Boston, MA, USA).
Wound healing assay
Horizontal lines (about 1 cm) were drawn on the back of the 6-well plate with marker. The cells were inoculated in the well. On the second day, the sterile pipette tip was utilized to scratch (perpendicular to the horizontal line on the back). The medium was removed, and washed with phosphate buffer saline (PBS), and then serum-free medium was added for incubating. Photographs were taken at 0 and 48 h, respectively.
Transwell assay
The transfected cells were digested with trypsin, and then centrifugated at 1000 rpm for 5 min. The supernatant was removed and resuspended with 5 mL sterile PBS. A small number of cells were taken and counted with a blood cell counting plate. The cells were centrifuged at 1000 rpm for 5 min and 3 mL serum-free medium was added to re-suspend the cells, and cell density was adjusted to 2 × 105/ml. Then 500 μL complete medium was added into the 24-well plates. The porous membrane was coated with Matrigel and 200 μL cells suspension were seeded into the upper chamber. After 48 h, the cells on the upper surface of the filter were removed, and that invaded to the lower surface were fixed and stained with 0.5% crystal violet, and counted under a light microscope.
PC transcriptome expression level data were obtained from TCGA database. The test platform was Illumina HiSeq 2000 RNA Sequencing. There were 551 samples in the dataset, and 548 (496 tumor and 52 normal) samples were included in the analysis after corresponding to the clinical information of PC samples. In addition, 6 androgen-related function terms (“androgen catabolic process”, “androgen biosynthetic process”, “androgen metabolic process”, “androgen receptor signaling pathway”, “regulation of androgen receptor signaling pathway”, and “negative regulation of androgen receptor signaling pathway”) were downloaded from the MSigDB module in Gene Set Enrichment Analysis (GSEA) database. The genes in these terms were considered as androgen-related genes.
Then, according to the sample information, the differentially expressed (DE) androgen-related genes between tumor and control samples were selected using R3.6.1 limma 3.34.7. The targets of m6A were downloaded from m6A2Target database, and the significantly DE androgen-related genes were mapped to the target genes to construct a regulatory network.
m6A RNA immunoprecipitation (MeRIP) sequencing
RNAs were extracted as above. The mRNA was fragmented to approximately 200 nt using RNA fragment reagent. A 5 μg fragment of mRNA was stored as input control of RNA sequence, and a 50 μg fragment of mRNA was used for MeRIP. Both the m6A IP samples and the input samples without IP were used to generate libraries for RNA sequencing. Libraries were sequenced on an Illumina Novaseq™ 6000 platform (LC-Bio Technology CO., Ltd., Hangzhou, China) with paired-end reads.
Sequence quality of IP and input samples were analyzed using FastQC and RseQC. HISAT2 was used for reference genome mapping. StringTie was used to analyze the expression level for all transcripts and genes from input libraries by calculating FPKM.
RNA m6A quantification
The m6A modification was detected using the EpiQuik m6A RNA Methylation Quantification Kit (P-9005; Epigentek Group Inc., USA). Briefly, 2 µL of negative control and 200 ng of RNA were added into strip wells. m6A was detected by capture and detection antibodies. The detected signal was enhanced and colorimetrically quantified at 450 nm.
Enzyme-linked immunosorbent assay (ELISA)
The AR level in supernatant was determined using the AR ELISA kit (ELK1829-1; ELK Biotechnology, Wuhan, China). The AR concentration was detected at a wavelength of 450 nm.
Subcutaneous xenografts of nude mice
Cells (si-NC group, si-YTHDF1 group, si-TRIM68 group, si-YTHDF1 + OE-TRIM68 group) were digested with 0.25% trypsin, and fetal bovine serum was added to prevent excessive digestion. After centrifugation at 1000 rpm for 5 min, cells were collected and suspended with culture medium without serum, and cell density was adjusted to 5 × 107 cells/ml.
SPF male BALB/c-nu nude mice (n = 20) were used in this study. Tumor cells (100 μl) were inoculated subcutaneously in the axils of the right forelimbs of mice. After the injection, the mental state, activity, diet, urine and feces of the nude mice were observed regularly every day. The body weight was measured weekly with an electronic balance, and the diameters of subcutaneous graft were measured weekly with vernier caliper. After the tumor grew to about 40 mm3, the nude mice were given flutamine (100 mg/kg; continuous administration for 1 week). The subcutaneous graft tumor volume V (mm3) = longest tumor diameter (mm) × shortest tumor diameter (mm) × 0.5. According to the tumor volume obtained, the growth curve of transplanted tumor was plotted.
Five weeks later, the mice were weighed, and sacrificed by cervical dislocation method. The tumor was separated and rinsed with sterile PBS, and then weighed. After weighing, whole blood was taken to separate serum, and tumor tissue was taken. One part was fixed in 4% paraformaldehyde solution, and the other part was stored at -80 °C.
The animal experiments were conducted according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by Institutional Animal Care and Use Committee of Ganzhou people's Hospital.
Hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC)
Prostate tissues were fixed in 4% paraformaldehyde, followed by rinsing with distilled water. The fixed tissues were embedded in paraffin, and sectioned (thickness: 4 μm). Then, sections were dewaxed and rehydrated, and then stained with H&E (Sigma, USA).
For IHC, the sections were blocked in 5% bovine serum albumin and then incubated with Ki67 antibodies (Cell signaling technology, MA, USA; Cat. #9027; 1:100) at 4 °C overnight, followed by incubation with secondary antibody for 80 min at 25 °C. Following that, 3,3′-diaminobenzidine development (DAB) and hematoxylin staining were carried out. The images were obtained with Olympus IX71 inverted microscope (Olympus, Japan).
Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay
TUNEL staining was performed using In situ cell death detection kit (11,684,795,910, Roche, Switzerland). Briefly, prostate tissue sections were permeabilized with proteinase K labeled with terminal deoxynucleotidyl transferase containing digoxigenin–dUTP and incubated with 3% hydrogen peroxide solution. Nuclear were stained with DAPI, and the positive cells were observed using immunofluorescence microscope (Nikon Eclipse 50i, Japan).
Statistical analyses
Data are presented as means ± standard deviation. Student t test was used for the comparison of two groups and one-way ANOVA for three or more groups. These analyses were based on Graphpad prism 5 (Graphpad Software, San Diego, CA, USA). P < 0.05 was considered significant.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.